Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial versus subcutaneous tumors, Proceedings of the National Academy of Sciences of the United States of America, vol.98, pp.4628-4633, 2001. ,
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome, The New England Journal of Medicine, vol.344, issue.14, pp.1038-1042, 2001. ,
Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies, Cancer Research, vol.30, issue.4, pp.1174-1184, 1970. ,
The biochemistry of P-glycoproteinmediated multidrug resistance, Annual Review of Biochemistry, vol.58, pp.137-171, 1989. ,
P-glycoprotein multidrug resistance and cancer, Biochimica et Biophysica Acta, vol.1288, issue.2, pp.37-54, 1996. ,
Biochemical, cellular, and pharmacological aspects of the multidrug transporter, Annual Review of Pharmacology and Toxicology, vol.39, pp.361-398, 1999. ,
P-glycoprotein: from genomics to mechanism, Oncogene, vol.22, issue.47, pp.7468-7485, 2003. ,
The physiological function of drugtransporting P-glycoproteins, Seminars in Cancer Biology, vol.8, issue.3, pp.161-170, 1997. ,
ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans, Journal of Molecular Biology, vol.293, issue.2, pp.381-399, 1999. ,
Relevance of multidrug resistance in the age of targeted therapy, Current opinion in Drug Discovery & Development, vol.12, pp.246-252, 2009. ,
Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance, Journal of the National Cancer Institute, vol.89, issue.13, pp.917-931, 1997. ,
Determining MDR1/P-glycoprotein expression in breast cancer, The International Journal of Cancer, vol.93, pp.114-122, 2001. ,
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations, Cancer Research, vol.56, issue.13, pp.3010-3020, 1996. ,
Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity, Blood, vol.87, issue.11, pp.4809-4816, 1996. ,
Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines, Canadian Journal of Physiology and Pharmacology, vol.80, issue.11, pp.1054-1063, 2002. ,
Different modalities of intercellular membrane exchanges mediate cellto-cell P-glycoprotein transfers in MCF-7 breast cancer cells, The Journal of Biological Chemistry, vol.287, issue.10, pp.7374-7387, 2012. ,
Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients, Blood, vol.91, issue.12, pp.4480-4488, 1998. ,
Fluorescent cellular indicators are extruded by the multidrug resistance protein, The Journal of Biological Chemistry, vol.268, issue.29, pp.21493-21496, 1993. ,
Cell responses to xenobiotics: comparison of MCF7 multi-drug-and mussel blood cell multi-xenobiotic-defense mechanisms, Marine Environmental Research, vol.58, issue.2-5, pp.209-213, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-02314844
Consequences of cell-to-cell P-glycoprotein transfer on acquired multidrug resistance in breast cancer: a cell population dynamics model, Biology Direct, vol.6, issue.5, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01738512
Comparison of methods of measuring blood pressure, Journal of Epidemiology and Community Health, vol.40, issue.3, pp.274-277, 1986. ,
Clinical effects on CA 15-3 level of cyclosporin A as a chemosensitiser in chemoresistant metastatic breast cancer, European Journal of Cancer A, vol.29, issue.3, p.480, 1993. ,